71 related articles for article (PubMed ID: 18789525)
1. Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression.
Toscan CE; Jing D; Mayoh C; Lock RB
Br J Cancer; 2020 Jun; 122(12):1769-1781. PubMed ID: 32242100
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia.
Autry RJ; Paugh SW; Carter R; Shi L; Liu J; Ferguson DC; Lau CE; Bonten EJ; Yang W; McCorkle JR; Beard JA; Panetta JC; Diedrich JD; Crews KR; Pei D; Coke CJ; Natarajan S; Khatamian A; Karol SE; Lopez-Lopez E; Diouf B; Smith C; Gocho Y; Hagiwara K; Roberts KG; Pounds S; Kornblau SM; Stock W; Paietta EM; Litzow MR; Inaba H; Mullighan CG; Jeha S; Pui CH; Cheng C; Savic D; Yu J; Gawad C; Relling MV; Yang JJ; Evans WE
Nat Cancer; 2020 Mar; 1(3):329-344. PubMed ID: 32885175
[TBL] [Abstract][Full Text] [Related]
3. How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer.
Clarisse D; De Bosscher K
Nat Commun; 2021 Aug; 12(1):4959. PubMed ID: 34400619
[TBL] [Abstract][Full Text] [Related]
4. GingerenoneA overcomes dexamethasone resistance by activating apoptosis and inhibiting cell proliferation in pediatric T-ALL cells.
Katebi M; Rahgozar S; Kazemi F; Rahmani S; Najafi Dorcheh S
Cancer Sci; 2023 Oct; 114(10):3984-3995. PubMed ID: 37619556
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone-Induced Fatty Acid Oxidation and Autophagy/Mitophagy Are Essential for T-ALL Glucocorticoid Resistance.
Olivas-Aguirre M; Pérez-Chávez J; Torres-López L; Hernández-Cruz A; Pottosin I; Dobrovinskaya O
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672393
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel glucocorticoid-resistant human B-cell acute lymphoblastic leukemia cell line, with AMPK, mTOR and fatty acid synthesis pathway inhibition.
Li Y; Zuo C; Gu L
Cancer Cell Int; 2021 Nov; 21(1):623. PubMed ID: 34823530
[TBL] [Abstract][Full Text] [Related]
7. Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol.
Olivas-Aguirre M; Torres-López L; Pottosin I; Dobrovinskaya O
Front Oncol; 2021; 11():617937. PubMed ID: 33777761
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency of
Xiao H; Ding Y; Gao Y; Wang LM; Wang H; Ding L; Li X; Yu X; Huang H
Cancer Cell Int; 2019; 19():218. PubMed ID: 31462891
[TBL] [Abstract][Full Text] [Related]
9. Effect of cAMP signaling on expression of glucocorticoid receptor, Bim and Bad in glucocorticoid-sensitive and resistant leukemic and multiple myeloma cells.
Dong H; Carlton ME; Lerner A; Epstein PM
Front Pharmacol; 2015; 6():230. PubMed ID: 26528184
[TBL] [Abstract][Full Text] [Related]
10. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.
Jones CL; Bhatla T; Blum R; Wang J; Paugh SW; Wen X; Bourgeois W; Bitterman DS; Raetz EA; Morrison DJ; Teachey DT; Evans WE; Garabedian MJ; Carroll WL
J Biol Chem; 2014 Jul; 289(30):20502-15. PubMed ID: 24895125
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of 11β-hydroxysteroid dehydrogenase type 2 by bortezomib sensitizes Jurkat leukemia T cells against glucocorticoid-induced apoptosis.
Tao Y; Gao L; Wu X; Wang H; Yang G; Zhan F; Shi J
PLoS One; 2013; 8(6):e67067. PubMed ID: 23826195
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.
Sionov RV
ISRN Hematol; 2013; 2013():348212. PubMed ID: 23431463
[TBL] [Abstract][Full Text] [Related]
13. Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
Lesovaya E; Yemelyanov A; Kirsanov K; Popa A; Belitsky G; Yakubovskaya M; Gordon LI; Rosen ST; Budunova I
Cell Cycle; 2013 Jan; 12(1):133-44. PubMed ID: 23255118
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance.
Gross KL; Oakley RH; Scoltock AB; Jewell CM; Cidlowski JA
Mol Endocrinol; 2011 Jul; 25(7):1087-99. PubMed ID: 21527497
[TBL] [Abstract][Full Text] [Related]
15. Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.
Beesley AH; Rampellini JL; Palmer ML; Heng JY; Samuels AL; Firth MJ; Ford J; Kees UR
Mol Cancer; 2010 Oct; 9():284. PubMed ID: 20979663
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes.
Smith LK; Cidlowski JA
Prog Brain Res; 2010; 182():1-30. PubMed ID: 20541659
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
Beesley AH; Firth MJ; Ford J; Weller RE; Freitas JR; Perera KU; Kees UR
Br J Cancer; 2009 Jun; 100(12):1926-36. PubMed ID: 19436302
[TBL] [Abstract][Full Text] [Related]
18. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
